Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 3546 entries
View as:

New Method Using Deuterium Labelled Creatine to Measure Total Body Skeletal Muscle Mass

Phase: N/A Priority: Normal
NCT ID: NCT02519751 Org: User:
Start: 10/31/14 End: 01/31/15 Due: 01/31/16

A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT01299597 Org: User:
Start: 01/18/10 End: 02/26/10 Due: 02/26/11

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00950612 Org: User:
Start: 12/08/09 End: 09/30/10 Due: 09/30/11

Pro-arrhythmic Potential of GSK3039294 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03567499 Org: User:
Start: 07/12/18 End: 05/03/19 Due: 05/03/20

Sumatriptan and Naratriptan Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT01059604 Org: User:
Start: 12/31/01 End: 04/30/13 Due: 04/30/14

Study to Investigate the Efficacy of an Occluding Dentifrice in Providing Relief From Dentine Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT02773758 Org: User:
Start: 01/01/16 End: 03/11/16 Due: 03/11/17

Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT01592851 Org: User:
Start: 04/30/12 End: 05/31/12 Due: 05/31/13

A Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01803399 Org: User:
Start: 08/31/14 End: 12/31/14 Due: 12/31/15

GSK2190915 Pediatric Study

Phase: N/A Priority: Normal
NCT ID: NCT01286844 Org: User:
Start: 11/30/10 End: 05/31/11 Due: 05/31/12

Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab

Phase: N/A Priority: Normal
NCT ID: NCT00933335 Org: User:
Start: 08/31/98 End: 08/31/10 Due: 08/31/11

A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01782664 Org: User:
Start: 03/01/13 End: 03/24/14 Due: 03/24/15

Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00791518 Org: User:
Start: 12/31/08 End: 05/31/09 Due: 05/31/10

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

Phase: N/A Priority: Normal
NCT ID: NCT00451321 Org: User:
Start: 07/31/06 End: 12/01/11 Due: 12/01/12

Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00454987 Org: User:
Start: 05/16/07 End: 10/12/07 Due: 10/12/08

Drug Use Investigation for Cervarix®

Phase: N/A Priority: Normal
NCT ID: NCT01187927 Org: User:
Start: 09/30/10 End: 01/31/14 Due: 01/31/15

Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02348372 Org: User:
Start: 03/31/11 End: 06/03/11 Due: 06/03/12

Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04053023 Org: User:
Start: 08/27/19 End: 11/25/19 Due: 11/25/20

An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT03557281 Org: User:
Start: 03/22/19 End: 12/14/21 Due: 12/14/22

A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT01114503 Org: User:
Start: 07/07/10 End: 08/29/12 Due: 08/29/13

Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden

Phase: N/A Priority: Normal
NCT ID: NCT00489567 Org: User:
Start: 10/31/07 End: 10/31/08 Due: 10/31/09

A Study of Belimumab in the Prevention of Kidney Transplant Rejection

Phase: N/A Priority: Normal
NCT ID: NCT01536379 Org: User:
Start: 09/30/13 End: 02/29/16 Due: 02/28/17

Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00434577 Org: User:
Start: 02/14/07 End: 07/14/10 Due: 07/14/11

Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2292767 in Healthy Participants Who Smoke Cigarettes

Phase: N/A Priority: Normal
NCT ID: NCT03045887 Org: User:
Start: 02/06/17 End: 08/16/17 Due: 08/16/18

Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

Phase: N/A Priority: Normal
NCT ID: NCT04915755 Org: User:
Start: 06/28/21 End: 12/31/25 Due: 12/31/26

A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00907985 Org: User:
Start: 05/15/09 End: 06/10/10 Due: 06/10/11